SPAK's investigations reveal the maneuver of Ilir Beqaj, how he favored the pharmaceutical company "Delta Pharma"

Since noon yesterday, by order of SPAK, BKH and the police are exercising control in the premises of the "Delta Pharma" pharmacy, but also in several other pharmacies, mainly in Tirana. The control comes thanks to a new criminal investigation, after indications that SPAK has received, where it is suspected that at the time when Ilir Beqaj was the Minister of Health, he signed client contracts with these pharmacies.
Sources indicate that the former minister Beqaj, at the time he took office as minister, through the modifications of the qualifying specifications, favored the company "Delta Pharma", writes Balkanweb.
It is learned that in the tender organized by the Ministry of Health in 2014, in the period March - April, after the tenders were published, a few days later a notice was issued to modify the qualifying specifications.
Sources confirm that, in a selective way, for some lots, the request for a Manufacturer's Authorization was removed, while it was left for all other lots. The specification has been removed for all Multinational companies such as Roche, Pfizer, Sanofi-Aventis, Bayer, Jansen Cilag, Abbvie, except Novartis.
According to what the sources confirm, all the companies opposed this, as it contradicted the drug law, which states that "the Minister of Health grants import permits for unregistered drugs", when chapter III, point 2 says: In cases of need to the health service (for outpatient and/or hospital treatment), for drugs that have no similar alternative, which has marketing authorization from the Agency, the minister responsible for health authorizes the import of drugs, for which no marketing authorization has been issued by The Agency, according to the rules determined by the decision of the Council of Ministers.
While all the drugs in these lots were registered. The minister did not stop the procedure even after the appeal, where the winning company for all the lots was "Delta Pharma", at the same time a distributor of Norvatis, which was the only multinational company that was not affected by these procedures, stating in the tender documents that the product you will get it in Turkey.
Even after complaining to the KPP, as well as direct communication from the companies, the former minister did not withdraw.
Sources confirm that no products were imported directly from Turkey, as stated in the offer. Likewise, all products were imported by "Delta Pharma Kosovo", the daughter company of "Delta Pharma Albania", without any accompanying documents according to the law, without a certificate of origin, and without a certificate of analysis, which are legal conditions even for registered drugs.
According to the sources, after this tender, the company "Delta Pharma", at the same time and representative of Novartis, had a favor in the inclusion in the reimbursement list of almost all products, while other companies did not enter any products. This is suspected to be related to the fact that one of the owners of "Delta Pharma", Dorian Sadiku, is the brother-in-law of the head of Novartis for Albania, Kliti Hoti.
According to the excerpt of the CKB, three members of the Sadiku family have left "Delta Pharma", the latter having signed a contract with Novartis. Sources confirm that Dorian Sadiku's brother-in-law was and is at the head of the latter, who returned in 2023 by buying "Delta Pharma", through the "Delta Holding" company, whose owners are Dorian Sadiku and Eduard Curraj.
According to the documents, it turns out that Dorian Sadiku, (brother-in-law of Kliti Hoti, head of Novartis), and Eduard Curraj owned 50% and 50% of the shares of "Delta Pharma". In 2023, Curraj sold his shares to Polish citizen Ewa Maria Kokot, but continues to be the administrator of this company.
Happening now...
83 mandates are not immunity for Rama's friends
ideas
top
Alfa recipes
TRENDING 
services
- POLICE129
- STREET POLICE126
- AMBULANCE112
- FIREFIGHTER128



